Checkpoint Therapeutics Correlations

CKPT Stock

USD 3.37 0.20 5.60%

The current 90-days correlation between Checkpoint Therapeutics and Fortress Biotech Pref is 0.18 (i.e., Average diversification). The correlation of Checkpoint Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Checkpoint Therapeutics Correlation With Market

Significant diversification

The correlation between Checkpoint Therapeutics and DJI is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Checkpoint Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Checkpoint Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Checkpoint Stock please use our How to Invest in Checkpoint Therapeutics guide.

Moving together with Checkpoint Stock

0.63	DYAI	Dyadic International	Pair Corr
0.76	ESPR	Esperion Therapeutics	Pair Corr
0.79	BMY	Bristol Myers Squibb	Pair Corr
0.81	GILD	Gilead Sciences	Pair Corr
0.76	MNMD	Mind Medicine	Pair Corr
0.67	MOLN	Molecular Partners	Pair Corr
0.82	ABCL	Abcellera Biologics	Pair Corr

Moving against Checkpoint Stock

0.8	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.75	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.72	VALN	Valneva SE ADR Upward Rally	Pair Corr
0.7	ERNA	Eterna Therapeutics	Pair Corr
0.69	LLY	Eli Lilly	Pair Corr
0.61	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.58	IMAB	I Mab	Pair Corr
0.54	GNFT	Genfit	Pair Corr
0.4	SLS	Sellas Life Sciences	Pair Corr
0.85	REGN	Regeneron Pharmaceuticals	Pair Corr
0.79	AKAN	Akanda Corp	Pair Corr
0.74	MRVI	Maravai Lifesciences	Pair Corr
0.71	AMGN	Amgen Inc	Pair Corr
0.7	NUVL	Nuvalent	Pair Corr
0.64	SXTPW	60 Degrees Pharmaceu	Pair Corr
0.49	ABBV	AbbVie Inc	Pair Corr
0.34	RANI	Rani Therapeutics	Pair Corr
0.87	TTOO	T2 Biosystms	Pair Corr
0.81	ANRO	Alto Neuroscience,	Pair Corr
0.72	BCDA	Biocardia	Pair Corr
0.65	APGE	Apogee Therapeutics,	Pair Corr
0.63	TFFP	Tff Pharmaceuticals	Pair Corr
0.6	ARDX	Ardelyx	Pair Corr

Related Correlations Analysis

	MBIO	RVPH	FBIOP	KOD	FBIO	ATXI	PIRS	ALRN	CTMX	TIL
MBIO		-0.38	-0.31	-0.56	-0.12	0.53	0.43	0.77	-0.26	0.15	MBIO
RVPH	-0.38		0.66	0.57	0.35	-0.38	-0.11	-0.59	0.36	-0.17	RVPH
FBIOP	-0.31	0.66		0.73	0.79	-0.4	0.0	-0.6	0.37	-0.42	FBIOP
KOD	-0.56	0.57	0.73		0.6	-0.7	-0.27	-0.82	-0.07	-0.72	KOD
FBIO	-0.12	0.35	0.79	0.6		-0.26	0.13	-0.35	0.21	-0.52	FBIO
ATXI	0.53	-0.38	-0.4	-0.7	-0.26		0.36	0.62	0.04	0.71	ATXI
PIRS	0.43	-0.11	0.0	-0.27	0.13	0.36		0.45	0.2	0.24	PIRS
ALRN	0.77	-0.59	-0.6	-0.82	-0.35	0.62	0.45		-0.11	0.41	ALRN
CTMX	-0.26	0.36	0.37	-0.07	0.21	0.04	0.2	-0.11		0.46	CTMX
TIL	0.15	-0.17	-0.42	-0.72	-0.52	0.71	0.24	0.41	0.46		TIL
	MBIO	RVPH	FBIOP	KOD	FBIO	ATXI	PIRS	ALRN	CTMX	TIL

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

FBIO	+ 0.79	FBIOP
ALRN	+ 0.77	MBIO
KOD	+ 0.73	FBIOP
TIL	+ 0.71	ATXI
FBIOP	+ 0.66	RVPH
ALRN	+ 0.62	ATXI

High negative correlations

ALRN	- 0.82	KOD
TIL	- 0.72	KOD
ATXI	- 0.7	KOD
ALRN	- 0.6	FBIOP
ALRN	- 0.59	RVPH
KOD	- 0.56	MBIO

Risk-Adjusted Indicators

There is a big difference between Checkpoint Stock performing well and Checkpoint Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Checkpoint Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
MBIO	3.61	(0.43)	0.00	1.45	0.00	0.00	6.90	(7.69)	41.50
RVPH	6.33	0.63	0.06	(1.05)	8.85	(7.36)	15.38	(11.88)	71.13
FBIOP	2.88	0.29	0.09	0.26	3.01	(3.49)	8.11	(6.24)	21.73
KOD	3.81	1.91	0.56	1.35	2.45	(5.01)	10.00	(4.87)	40.23
FBIO	3.75	(0.06)	0.00	(0.02)	0.00	0.00	9.52	(5.78)	22.17
ATXI	3.39	(0.51)	0.00	1.37	0.00	0.00	6.81	(6.67)	24.31
PIRS	1.68	(0.32)	0.00	(1.24)	0.00	0.00	3.23	(3.40)	10.25
ALRN	4.51	(0.46)	0.00	(0.54)	0.00	0.00	9.81	(9.43)	41.47
CTMX	3.10	(0.08)	0.00	(0.03)	0.00	0.00	6.78	(5.49)	22.92
TIL	5.77	(1.60)	0.00	(0.71)	0.00	0.00	12.77	(10.84)	30.36

Checkpoint Therapeutics Corporate Executives

Elected by the shareholders, the Checkpoint Therapeutics' board of directors comprises two types of representatives: Checkpoint Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Checkpoint. The board's role is to monitor Checkpoint Therapeutics' management team and ensure that shareholders' interests are well served. Checkpoint Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Checkpoint Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.

William Gray

Corporate CFO

Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC